SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-22-003306
Filing Date
2022-11-14
Accepted
2022-11-14 12:05:37
Documents
61
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q eyen-20220930x10q.htm   iXBRL 10-Q 1301323
2 EX-10.1 eyen-20220930xex10d1.htm EX-10.1 13191
3 EX-31.1 eyen-20220930xex31d1.htm EX-31.1 12796
4 EX-31.2 eyen-20220930xex31d2.htm EX-31.2 12780
5 EX-32.1 eyen-20220930xex32d1.htm EX-32.1 6218
6 EX-32.2 eyen-20220930xex32d2.htm EX-32.2 6012
  Complete submission text file 0001410578-22-003306.txt   5726439

Data Files

Seq Description Document Type Size
7 EX-101.SCH eyen-20220930.xsd EX-101.SCH 54387
8 EX-101.CAL eyen-20220930_cal.xml EX-101.CAL 43915
9 EX-101.DEF eyen-20220930_def.xml EX-101.DEF 154869
10 EX-101.LAB eyen-20220930_lab.xml EX-101.LAB 367722
11 EX-101.PRE eyen-20220930_pre.xml EX-101.PRE 301803
55 EXTRACTED XBRL INSTANCE DOCUMENT eyen-20220930x10q_htm.xml XML 954790
Mailing Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017
Business Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017 813-766-9539
EYENOVIA, INC. (Filer) CIK: 0001682639 (see all company filings)

IRS No.: 471178401 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38365 | Film No.: 221382616
SIC: 2834 Pharmaceutical Preparations